Biogen maps way to future factory


Biogen Idec sees the bioprocessing factory of its future. It's not some pie-in-the-sky concept, but the result of a technology map created collaboratively by the company's heads of engineering, development and manufacturing to help coordinate their forward-looking thinking.

Here's what the company sees: smaller, more flexible facilities based on new technologies to improve production results in line with changes in demand and changes in the pace of production. The vision includes little of the $500 million to $1 billion worth of stainless steel bioreactors, piping, instrumentation, equipment and support systems of traditional bioprocess plants, reports Investor's Business Daily. Shiny two- to three-story bioreactors will give way to much smaller disposable bags and single-use technology components.

"By changing the equipment, the time it takes to bring into operation a new plant is transformed," says John Cox, EVP for pharma ops and technology, in the article.


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.

The map-building is ultimately a silo-buster, too. The technique helps the company leaders coordinate their thinking. And as their coordinated ideas become manufacturing and operations reality, traditional barriers between the three functions will no longer be sustained.